These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37777572)

  • 1. Alternative beliefs in psychedelic drug users.
    Lebedev AV; Acar K; Horntvedt O; Cabrera AE; Simonsson O; Osika W; Ingvar M; Petrovic P
    Sci Rep; 2023 Sep; 13(1):16432. PubMed ID: 37777572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelic drug use and schizotypy in young adults.
    Lebedev AV; Acar K; Garzón B; Almeida R; Råback J; Åberg A; Martinsson S; Olsson A; Louzolo A; Pärnamets P; Lövden M; Atlas L; Ingvar M; Petrovic P
    Sci Rep; 2021 Jul; 11(1):15058. PubMed ID: 34301969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contextual Parameters Associated with Positive and Negative Mental Health in Recreational Psychedelic Users.
    St Arnaud KO; Sharpe D
    J Psychoactive Drugs; 2023; 55(1):30-39. PubMed ID: 35156542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Values and beliefs of psychedelic drug users: a cross-cultural study.
    Lerner M; Lyvers M
    J Psychoactive Drugs; 2006 Jun; 38(2):143-7. PubMed ID: 16903453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.
    Corrigan K; Haran M; McCandliss C; McManus R; Cleary S; Trant R; Kelly Y; Ledden K; Rush G; O'Keane V; Kelly JR
    Ir J Med Sci; 2022 Jun; 191(3):1385-1397. PubMed ID: 34131812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between lifetime classic psychedelic use and markers of physical health.
    Simonsson O; Sexton JD; Hendricks PS
    J Psychopharmacol; 2021 Apr; 35(4):447-452. PubMed ID: 33719688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of psychedelic use and opioid use disorders among illicit users in the United States.
    Pisano VD; Putnam NP; Kramer HM; Franciotti KJ; Halpern JH; Holden SC
    J Psychopharmacol; 2017 May; 31(5):606-613. PubMed ID: 28196428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.
    Davis AK; Agin-Liebes G; España M; Pilecki B; Luoma J
    J Psychoactive Drugs; 2022; 54(4):309-318. PubMed ID: 34468293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner.
    Kettner H; Gandy S; Haijen ECHM; Carhart-Harris RL
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31888300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and epidemiological associates of novel psychedelic use in the United States adult population.
    Sexton JD; Crawford MS; Sweat NW; Varley A; Green EE; Hendricks PS
    J Psychopharmacol; 2019 Sep; 33(9):1058-1067. PubMed ID: 30816808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers.
    Erritzoe D; Smith J; Fisher PM; Carhart-Harris R; Frokjaer VG; Knudsen GM
    J Psychopharmacol; 2019 Sep; 33(9):1068-1075. PubMed ID: 30816797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case analysis of long-term negative psychological responses to psychedelics.
    Bremler R; Katati N; Shergill P; Erritzoe D; Carhart-Harris RL
    Sci Rep; 2023 Sep; 13(1):15998. PubMed ID: 37749109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.
    Lea T; Amada N; Jungaberle H; Schecke H; Scherbaum N; Klein M
    Psychopharmacology (Berl); 2020 May; 237(5):1521-1532. PubMed ID: 32043165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why psychiatry needs psychedelics and psychedelics need psychiatry.
    Sessa B
    J Psychoactive Drugs; 2014; 46(1):57-62. PubMed ID: 24830186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of knowledge on attitudes of emergency department staff towards patients with substance related presentations: a quantitative systematic review protocol.
    Clarke DE; Gonzalez M; Pereira A; Boyce-Gaudreau K; Waldman C; Demczuk L
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):133-45. PubMed ID: 26571289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.
    Révész D; Ona G; Rossi GN; Rocha JM; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
    Front Psychiatry; 2021; 12():687546. PubMed ID: 34220590
    [No Abstract]   [Full Text] [Related]  

  • 17. Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data.
    Barnett BS; Ziegler K; Doblin R; Carlo AD
    J Psychopharmacol; 2022 Oct; 36(10):1118-1128. PubMed ID: 35971893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting.
    Argento E; Strathdee SA; Tupper K; Braschel M; Wood E; Shannon K
    BMJ Open; 2017 Sep; 7(9):e016025. PubMed ID: 28939573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.
    Bouso JC; Palhano-Fontes F; Rodríguez-Fornells A; Ribeiro S; Sanches R; Crippa JA; Hallak JE; de Araujo DB; Riba J
    Eur Neuropsychopharmacol; 2015 Apr; 25(4):483-92. PubMed ID: 25637267
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.